Rawas-Qalaji M - Search Results

1

Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis.

Rawas-Qalaji M, Bafail R, Cagliani R, Haider M, Hussain Z. Rawas-Qalaji M, et al. Eur J Pharm Sci. 2021 Dec 1;167:106025. doi: 10.1016/j.ejps.2021.106025. Epub 2021 Sep 29. Eur J Pharm Sci. 2021. PMID: 34600046

2

Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. J Allergy Clin Immunol. 2006 Feb;117(2):398-403. doi: 10.1016/j.jaci.2005.12.1310. J Allergy Clin Immunol. 2006. PMID: 16461140

3

Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Biopharm Drug Dispos. 2006 Dec;27(9):427-35. doi: 10.1002/bdd.519. Biopharm Drug Dispos. 2006. PMID: 17009337

4

Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Drug Dev Ind Pharm. 2007 May;33(5):523-30. doi: 10.1080/03639040600897150. Drug Dev Ind Pharm. 2007. PMID: 17520443

5

Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis.

Rawas-Qalaji M, Simons FE, Collins D, Simons KJ. Rawas-Qalaji M, et al. Ann Allergy Asthma Immunol. 2009 Jun;102(6):500-3. doi: 10.1016/S1081-1206(10)60124-X. Ann Allergy Asthma Immunol. 2009. PMID: 19558009

6

Long-term stability of epinephrine sublingual tablets for the potential first-aid treatment of anaphylaxis.

Rawas-Qalaji MM, Rachid O, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Ann Allergy Asthma Immunol. 2013 Dec;111(6):568-70. doi: 10.1016/j.anai.2013.09.005. Epub 2013 Sep 29. Ann Allergy Asthma Immunol. 2013. PMID: 24267371 No abstract available.

7

Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.

Rawas-Qalaji M, Rachid O, Mendez BA, Losada A, Simons FE, Simons KJ. Rawas-Qalaji M, et al. J Pharm Pharmacol. 2015 Jan;67(1):20-5. doi: 10.1111/jphp.12312. Epub 2014 Sep 26. J Pharm Pharmacol. 2015. PMID: 25256073

8

Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.

Rawas-Qalaji MM, Werdy S, Rachid O, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. AAPS PharmSciTech. 2015 Oct;16(5):1203-12. doi: 10.1208/s12249-015-0306-0. Epub 2015 Mar 4. AAPS PharmSciTech. 2015. PMID: 25732373 Free PMC article.

9

Epinephrine doses delivered from auto-injectors stored at excessively high temperatures.

Rachid O, Simons FE, Rawas-Qalaji M, Lewis S, Simons KJ. Rachid O, et al. Drug Dev Ind Pharm. 2016 Jan;42(1):131-135. doi: 10.3109/03639045.2015.1035283. Epub 2015 May 22. Drug Dev Ind Pharm. 2016. PMID: 25997362

10

Formulation and Evaluation of Fast-Disintegrating Sublingual Tablets of Atropine Sulfate: the Effect of Tablet Dimensions and Drug Load on Tablet Characteristics.

Aodah A, Bafail RS, Rawas-Qalaji M. Aodah A, et al. AAPS PharmSciTech. 2017 Jul;18(5):1624-1633. doi: 10.1208/s12249-016-0631-y. Epub 2016 Sep 20. AAPS PharmSciTech. 2017. PMID: 27650282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters